Incyte to Present at Upcoming Investor Conference
17 Dezembro 2024 - 10:00AM
Business Wire
Incyte (Nasdaq: INCY) announced today that it will present at
the 43rd Annual J. P. Morgan Healthcare Conference on Monday,
January 13, 2025 at 10:30 am (PST).
The presentation will be webcast live and can be accessed at
Investor.Incyte.com and will be available for replay for 30
days.
About Incyte
A global biopharmaceutical company on a mission to Solve On.,
Incyte follows the science to find solutions for patients with
unmet medical needs. Through the discovery, development and
commercialization of proprietary therapeutics, Incyte has
established a portfolio of first-in-class medicines for patients
and a strong pipeline of products in Oncology and Inflammation
& Autoimmunity. Headquartered in Wilmington, Delaware, Incyte
has operations in North America, Europe and Asia.
For additional information on Incyte, please visit Incyte.com or
follow us on social media: LinkedIn, X, Instagram, Facebook,
YouTube.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241217310994/en/
Incyte Media
media@incyte.com
Investors ir@incyte.com
Incyte (NASDAQ:INCY)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Incyte (NASDAQ:INCY)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025
